A review on synthetic strategy, molecular pharmacology of indazole derivatives, and their future perspective. Issue 7 (16th August 2022)
- Record Type:
- Journal Article
- Title:
- A review on synthetic strategy, molecular pharmacology of indazole derivatives, and their future perspective. Issue 7 (16th August 2022)
- Main Title:
- A review on synthetic strategy, molecular pharmacology of indazole derivatives, and their future perspective
- Authors:
- Mal, Suvadeep
Malik, Udita
Mahapatra, Monalisa
Mishra, Abhishek
Pal, Dilipkumar
Paidesetty, Sudhir K. - Abstract:
- Abstract: With different nitrogen‐containing heterocyclic moieties, Indazoles earn one of the places among the top investigated molecules in medicinal research. Indazole, an important fused aromatic heterocyclic system containing benzene and pyrazole ring with a chemical formula of C7 H6 N2, is also called benzopyrazole. Indazoles consist of three tautomeric forms in which 1 H ‐tautomers (indazoles) and 2 H ‐tautomers (isoindazoles) exist in all phases. The tautomerism in indazoles greatly influences synthesis, reactivity, physical and even the biological properties of indazoles. The thermodynamic internal energy calculation of these tautomers points view 1 H ‐indazole as the predominant and stable form over 2 H ‐indazole. The natural source of indazole is limited and exists in alkaloidal nature (i.e., nigellidine, nigeglanine, nigellicine, etc.) found from Nigella plants. Some of the FDA‐approved drugs like Axitinib, Entrectinib, Niraparib, Benzydamine, and Granisetron are being used to treat renal cell cancer, non‐small cell lung cancer (NSCLC), epithelial ovarian cancer, chronic inflammation, chemotherapy‐induced nausea, vomiting, and many more uses. Besides all these advantages regarding its biological activity, the main issue about indazoles is the less abundance in plant sources, and their synthetic derivatives also often face problems with low yield. In this review article, we discuss its chemistry, tautomerism along with their effects, different schematics for theAbstract: With different nitrogen‐containing heterocyclic moieties, Indazoles earn one of the places among the top investigated molecules in medicinal research. Indazole, an important fused aromatic heterocyclic system containing benzene and pyrazole ring with a chemical formula of C7 H6 N2, is also called benzopyrazole. Indazoles consist of three tautomeric forms in which 1 H ‐tautomers (indazoles) and 2 H ‐tautomers (isoindazoles) exist in all phases. The tautomerism in indazoles greatly influences synthesis, reactivity, physical and even the biological properties of indazoles. The thermodynamic internal energy calculation of these tautomers points view 1 H ‐indazole as the predominant and stable form over 2 H ‐indazole. The natural source of indazole is limited and exists in alkaloidal nature (i.e., nigellidine, nigeglanine, nigellicine, etc.) found from Nigella plants. Some of the FDA‐approved drugs like Axitinib, Entrectinib, Niraparib, Benzydamine, and Granisetron are being used to treat renal cell cancer, non‐small cell lung cancer (NSCLC), epithelial ovarian cancer, chronic inflammation, chemotherapy‐induced nausea, vomiting, and many more uses. Besides all these advantages regarding its biological activity, the main issue about indazoles is the less abundance in plant sources, and their synthetic derivatives also often face problems with low yield. In this review article, we discuss its chemistry, tautomerism along with their effects, different schematics for the synthesis of indazole derivatives, and their different biological activities. … (more)
- Is Part Of:
- Drug development research. Volume 83:Issue 7(2022)
- Journal:
- Drug development research
- Issue:
- Volume 83:Issue 7(2022)
- Issue Display:
- Volume 83, Issue 7 (2022)
- Year:
- 2022
- Volume:
- 83
- Issue:
- 7
- Issue Sort Value:
- 2022-0083-0007-0000
- Page Start:
- 1469
- Page End:
- 1504
- Publication Date:
- 2022-08-16
- Subjects:
- analgesic -- anticancer -- anti‐inflammatory -- benzopyrazole -- indazole -- SARs -- tautomers
Drug development -- Periodicals
Drugs -- Research -- Periodicals
615.19 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-2299 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/ddr.21979 ↗
- Languages:
- English
- ISSNs:
- 0272-4391
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.119000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24420.xml